DEFA14A ·Filed Apr 21, 2026

TRVI

Trevi Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001193125-26-166693
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no immediate financial impact. Monitor for any changes in governance or compensation policies.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
TRVI ▲ +28.85% at T+60d
NEUTRAL call ✓ call won +28.85% · α vs SPY +24.07% · entry $14.80 → $19.07
Entry anchored
Apr 21, 03:59 PM ET
via exchange tick
T+1d
-4.12%
call -4.12% · α -3.73%
$14.19
settled 5mo ago
T+5d
-7.97%
call -7.97% · α -8.03%
$13.62
settled 5mo ago
T+20d
-10.54%
call -10.54% · α -13.71%
$13.24
settled 5mo ago
T+60d
+28.85%
call +28.85% · α +24.07%
$19.07
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Trevi Therapeutics is holding its 2026 annual meeting where shareholders will vote on several proposals including electing a director, ratifying auditors, approving executive compensation, amending the stock incentive plan, and increasing authorized shares. This is a routine annual shareholder meeting.

Key Facts

  • Annual meeting to vote on director election, auditor ratification, executive compensation, stock incentive plan amendment, and share authorization
  • Board recommends voting for all proposals
  • Meeting date: June 3, 2026

Financial Impact

No immediate financial impact

sharescompensationgovernance

Risk Factors

  • Potential shareholder dissent on executive compensation
  • Possible opposition to share increase

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-166693
Document: 0001193125-26-166693-index-headers.html0001193125-26-166693
Document: 0001193125-26-166693-index.html0001193125-26-166693
Document: 0001193125-26-166693.txt0001193125-26-166693
10 reports for TRVI
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +15.38%Mar 9, 2026
Filters
Rows
Reports for TRVI — sortable, filterable
TypeNow
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 5/10
$13.46 $17.26▲ +28.23%▲ +23.84%$13.94 (+3.53%)
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$13.46 $17.26▲ +28.23%▲ +23.84%$13.94 (+3.53%)
Apr 21, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$14.80 $19.07▲ +28.85%▲ +24.07%$13.94 (−5.84%)
Apr 20, 2026
23w ago
Press Release
NEUTRAL ★ 5/10
$14.62 $17.36▲ +18.74%▲ +11.84%$13.94 (−4.69%)
Apr 17, 2026
23w ago
424B5
BEARISH ★ 7/10
$15.40 $18.15▼ −17.82%▼ −11.05%$13.94 (+9.51%)
Apr 17, 2026
24w ago
8-K
BEARISH ★ 7/10
$15.23 $17.91▼ −17.60%▼ −11.45%$13.94 (+8.50%)
Apr 17, 2026
24w ago
Press Release
NEUTRAL ★ 6/10
$15.23 $17.91▲ +17.60%▲ +11.45%$13.94 (−8.50%)
Mar 17, 2026
28w ago
Press Release
MIXED ★ 6/10
$10.69 $13.46▲ +25.91%▲ +14.39%$13.94 (+30.36%)
Mar 10, 2026
29w ago
Press Release
NEUTRAL ★ 3/10
$11.94 $13.45▲ +12.65%▲ +1.12%$13.94 (+16.71%)
Mar 9, 2026
29w ago
Press Release
BULLISH ★ 7/10
$11.70 $13.50▲ +15.38%▲ +3.40%$13.94 (+19.10%)
Showing 10 of 10

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access